STRUCTURAL AND FUNCTIONAL CHANGES IN OSTEOGENIC CELLS AND BIOMARKERS OF BONE REMODELING IN CHRONIC HYPERGLYCEMIA
Open Access
- 1 January 2023
- journal article
- research article
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 11 (4) , 398-407
Abstract
Analysis of the results of experimental studies on skeletal bone structure disorders in the setting of hyperglycemia discovered a lack of information on the peculiarities of the remodeling process and structural and functional changes of osteogenic cells in long tubular bones depending on the duration of diabetes mellitus. Objective. Therefore, the aim of our experimental study was to determine the peculiarities of the effect of hyperglycemia on bone remodeling and structural and functional changes in osteogenic cells of long tubular bones of mature rats. Methods and Materials. Methods used to study the structure of femurs: 1) transmission electron microscopy, 2) immunohistochemical examination. In the study of osteoblasts, special attention was paid to the integrity of cellular structures and membrane organelles, the presence of cytoplasmic vacuolization. Results. Analysis of the osteogenic activity in the bone tissue of the experimental group showed that an increase in blood glucose leads to a change in the concentration of osteopontin, which directly affects the formation of bone tissue. The immunohistochemical study of osteogenic cells revealed a significant disruption of the structure of organelles, which leads to a disruption of the normal functioning of these cells, which is manifested in a decrease in osteopontin levels and a gradual increase in RANKL. Conclusions. It can be noted that under hyperglycemia conditions, structural disorders of osteoblasts occur already on the 30th day of the experiment: significant hypertrophy of the granular endoplasmic reticulum (GER), increasing destruction of membrane organelles with further progression in accordance with the increase in the duration of chronic hyperglycemia.Keywords
This publication has 24 references indexed in Scilit:
- The increase in bone resorption in early-stage type I diabetic mice is induced by RANKL secreted by increased bone marrow adipocytesBiochemical and Biophysical Research Communications, 2020
- Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetesScientific Reports, 2019
- Altered bone microarchitecture in a type 1 diabetes mouse model Ins2AkitaJournal of Cellular Physiology, 2018
- Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes MellitusFrontiers in Endocrinology, 2017
- Energy Metabolism of the Osteoblast: Implications for OsteoporosisEndocrine Reviews, 2017
- The effect of hyperglycaemia on osseointegration: a review of animal models of diabetes mellitus and titanium implant placementArchives of Osteoporosis, 2016
- Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic ratsJournal of Molecular Histology, 2008
- Minireview: The OPG/RANKL/RANK SystemEndocrinology, 2001
- The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated**This work was supported by Grant AG-04875 from the National Institute on Aging.Endocrinology, 2000
- Osteoprotegerin and its Ligand: A New Paradigm for Regulation of Osteoclastogenesis and Bone ResorptionOsteoporosis International, 2000